Skip to main content
Equibles
BTAIQ logo

BTAIQ · BioXcel Therapeutics, Inc.

Track BTAIQ — free

Use BTAIQ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTAIQ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.05 +0.01 (+15.56%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$1.19M
Shares
31.31M
Volume · Oct 2 347.7K Avg daily vol (3M) 6.22M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.05 Open$0.05 Day$0.05–0.06 52W close$0.04–2.78 Avg vol 30d11.8M Short int3.1M · 9.9% float · 1.0d Short vol24% Last earningsDec 8, 2025 DataJan 2020–Oct 2026 Filing10-Q · Aug 13

Up next

Latest filing: 10-Q
filed Aug 13, 2026
Q3 2024 earnings call transcript
call held Nov 14, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-98.0%
Trailing year
Short interest
9.9%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −95%
below
Price vs 50-day avg −89%
below
RSI (14) 27
oversold
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −56%
trailing
6-month return −95%
trailing
YTD return −97%
this year
Relative strength −107%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+18% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.85% of float · ▼ -49.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
47 holders — mid 3-yr range
Squeeze score 46
elevated · 0–100
Fundamentals
Weak
Revenue growth −72%
Y/Y
EPS growth +76%
Y/Y
Free cash flow $-57.6M
Balance sheet $81.2M
net debt
Quant / Vol
risk profile
Very High
Volatility 155%
annualized · 1-yr
Max drawdown −99%
past year
ATR 76.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−95% Bearish
Price vs 50-day avg
−89% Bearish
RSI (14)
27 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+18% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.85% of float · ▼ -49.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
47 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $0 · 1% Range high $3
vs 200-day avg -95% vs 50-day avg -89%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BTAIQ
BioXcel Therapeutics, Inc.
this stock
$1.19M -96.8% -71.7% — 9.9%
TAK
Takeda Pharmaceutical Co Ltd
 $60.23B +14.6% — — 0.1%
GALDY
Galderma Group AG/ADR
 $46.00B -6.5% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.67B +26.7% +4.3% 64.3 2.7%
HLN
Haleon plc
 $40.72B -13.0% — — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
47
% held
19.7%
Net QoQ
+734.8K sh
Top holder
MILLENNIUM MANAGEMENT LLC
Held Float
View
Held by Funds
Fund positions
4
View
Short & Settlement
Short Interest Falling
Shares short
3.1M
Days to cover
1.0d
Change
-3.0M sh
View
Short Volume
Short vol %
24%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
4.8K
Value
$240
As of
Sep 11, 2026
View
Financials
Financials
Revenue (FY)
$642.0K
Net income (FY)
$-69.9M
EPS diluted
$-5.73
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 1, 2026
This year
19
View
Proposed Sales
Value
$7.1K
Shares
6.6K
Filed
May 20, 2026
View
Earnings & Events
Webcasts
Last webcast
Dec 8, 2025
View

Performance

5D 20D 120D MTD YTD
BTAIQ +26.8% -55.9% -94.9% +5.1% -96.8%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +27.1% -55.5% -107.1% +4.1% -109.6%
Key facts CIK 1720893 Visit website Investor relations